Lead global market access and pricing strategy for Mezagitamab (TAK-079), an innovative auto-immune asset, to secure optimal reimbursement, patient access, and value realization across key markets. As a member of the global product and commercial teams and relevant cross-functional teams, you will shape payer value strategy, Health Technology Assessment (HTA) positioning, and evidence generation from early development through launch. You will provide cross-functional leadership across R&D, Medical, SPD, Key Markets, International Business Unit, and other cross-functional partners, ensuring aligned, high-impact access strategies and supporting execution and driving launch readiness through robust global planning, local adaptation, and effective execution in core markets and working very closely with IBU Specialty Care to ensure readiness beyond core countries.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior